CN105412378A - Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis - Google Patents
Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis Download PDFInfo
- Publication number
- CN105412378A CN105412378A CN201610017575.3A CN201610017575A CN105412378A CN 105412378 A CN105412378 A CN 105412378A CN 201610017575 A CN201610017575 A CN 201610017575A CN 105412378 A CN105412378 A CN 105412378A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis. The traditional Chinese medicine composition is prepared from, by weight, 15-25 parts of radix cyathulae, 15-25 parts of vervain, 15-25 parts of rhizoma corydalis, 10-15 parts of astragalus membranaceus, 10-15 parts of cistanche, 10-15 parts of radix paeoniae alba, 10-15 parts of eclipta, 10-15 parts of glossy privet fruits, 5-10 parts of nutmeg, 5-10 parts of sanguisorba officinalis, 10-15 parts of lysimachia christinae hance, 10-15 parts of polygala tenuifolia, 5-10 parts of szechwan Chinaberry fruits, 5-10 parts of ligusticum wallichii, 5-10 parts of rhubarb, 5-10 parts of fortune eupatorium herbs, 5-10 parts of platycodon grandiflorum, 5-10 parts of radix stemonae, 15-25 parts of rhizoma sparganii, 15-25 parts of caulis bambusae in taeniam, 10-15 parts of brucea javanica, 10-15 parts of moutan bark and 5-10 parts of liquorice. The traditional Chinese medicine composition can promote blood circulation to remove blood stasis, activate meridians to stop pain, tonify the liver and kidney, strengthen tendons and bones, expel wind and remove cold, clear away heat and toxic materials and tonify middle-Jiao and Qi, can be used for treating hyperostosis and cervical spondylosis, can also be used for treating various lower back pains and leg pains, numbness of limbs, protrusion of intervertebral disc, scapulohumeral periarthritis, lumbar muscle degeneration and the like, is free of toxic or side effect, and has a remarkable curative effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, in particular to a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis.
Background technology
Bone matrix hyperplasia, cervical spondylosis belong to the category of the traditional Chinese medical science " arthromyodynia ", " rheumatism involving the bone ".Support because congenital defect or the day after tomorrow lose, cause Liver and kidney two empty, be difficult to full muscles and bones, bone is withered, and marrow subtracts, and thus sclerotin loosens, and long-term over loading is born a heavy burden, skeleton and then distortion, and muscles and bones must not be moistened and be moistened foster, then occur arthralgia, movable unfavorable.
Traditional Chinese Medicine is thought, it is obstructed that " arthromyodynia " arises from QI and blood, body fluid can not moisten foster body parts, as essence and blood retardance, cyclic metabolism is not normal, cause local proliferation or strain, and blood stored in the liver adjusts blood, kidney governing bones store essential substances (nutrition), Liver and kidney function declines, gas can be stagnant, the stagnation of QI blood then stasis of blood, blood stasis causes hypertrophy or strain, visible " numbness " is originally not smooth in QI and blood, QI and blood is smooth originally in Liver and kidney disturbance in functioning of QI, function declines, metabolism is not normal, and current most of application compress are only focused on invigorating blood circulation, cure the symptoms, not the disease, except wound, dysplasia, position is not just waiting outside external cause, the true cause of hypertrophy and strain is that Liver and kidney function declines, imbalance causes, this is endogenous cause of ill.
The western medical treatment of current treatment hyperosteogeny, cervical spondylosis, usually adopts and eats analgesic, plays pain killer injection relief of symptoms and operation and operate on treatment, and Western medicine can only respite pain and side effect is larger, open surgery treatment difficulty is large, costly, general patient is difficult to bear, and recurrence can not be effected a radical cure.Traditional Chinese medical herbal treatment, is divided into internal treatment and external treatment, and internal treatment i.e. for oral administration decoction, pill etc., external treatment and patch, fumigation and wash method, external application etc., no matter be treatment by oral administration of medicines, external treatment has certain curative effect, but exist take effect slow, the course for the treatment of is oversize, patient is difficult to problems such as adhering to.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis, based on the dialectical prescription of tcm theory, there is effect of blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, liver and kidney tonifying, bone and muscle strengthening, expelling wind and cold, heat-clearing and toxic substances removing, invigorating the spleen and replenishing QI, can be used for treating hyperosteogeny, cervical spondylosis, also can be used for treating the diseases such as various lumbago, skelalgia, numb limbs and tense tendons, intervertebral disk hernia, scapulohumeral periarthritis, lumbar muscle strain, have no side effect, therapeutic effect is remarkable.
Concrete, one aspect of the present invention provides a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis, is made up: Radix Cyathulae, Herba Verbenae, Rhizoma Corydalis, the Radix Astragali of the crude drug of following weight portion.
In the present invention's detailed description of the invention, described a kind ofly treat hyperosteogeny, the Chinese medicine composition of cervical spondylosis is made up of the crude drug of following weight portion: Radix Cyathulae 15-25 part, Herba Verbenae 15-25 part, Rhizoma Corydalis 15-25 part, Radix Astragali 10-15 part.
In the present invention's detailed description of the invention, described one treats hyperosteogeny, the Chinese medicine composition of cervical spondylosis is made up of the crude drug of following weight portion: Radix Cyathulae 15-25 part, Herba Verbenae 15-25 part, Rhizoma Corydalis 15-25 part, Radix Astragali 10-15 part, Herba Cistanches 10-15 part, Radix Paeoniae Alba 10-15 part, Herba Ecliptae 10-15 part, Fructus Ligustri Lucidi 10-15 part, Semen Myristicae 5-10 part, Radix Sanguisorbae 5-10 part, Herba Lysimachiae 10-15 part, Radix Polygalae 10-15 part, Fructus Toosendan 5-10 part, Rhizoma Chuanxiong 5-10 part, Radix Et Rhizoma Rhei 5-10 part, Herba Eupatorii 5-10 part, Radix Platycodonis 5-10 part, Radix Stemonae 5-10 part, Rhizoma Sparganii 15-25 part, Caulis Bambusae In Taenia 15-25 part, Fructus Bruceae 10-15 part, Cortex Moutan 10-15 part, Radix Glycyrrhizae 5-10 part.
In the present invention's detailed description of the invention, described a kind ofly treat hyperosteogeny, the Chinese medicine composition of cervical spondylosis is made up of the crude drug of following weight portion: Radix Cyathulae 20 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 20 parts, the Radix Astragali 13 parts, Herba Cistanches 12 parts, the Radix Paeoniae Alba 12 parts, Herba Ecliptae 13 parts, Fructus Ligustri Lucidi 12 parts, Semen Myristicae 8 parts, Radix Sanguisorbae 7 parts, Herba Lysimachiae 12 parts, Radix Polygalae 13 parts, Fructus Toosendan 7 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 7 parts, the Radix Stemonae 7 parts, Rhizoma Sparganii 20 parts, Caulis Bambusae In Taenia 20 parts, Fructus Bruceae 12 parts, Cortex Moutan 13 parts, 8 parts, Radix Glycyrrhizae.
In the present invention's detailed description of the invention, described a kind ofly treat hyperosteogeny, the Chinese medicine composition of cervical spondylosis is made up of the crude drug of following weight portion: Radix Cyathulae 16 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 17 parts, the Radix Astragali 14 parts, Herba Cistanches 11 parts, the Radix Paeoniae Alba 13 parts, Herba Ecliptae 12 parts, Fructus Ligustri Lucidi 14 parts, Semen Myristicae 6 parts, Radix Sanguisorbae 9 parts, Herba Lysimachiae 11 parts, Radix Polygalae 14 parts, Fructus Toosendan 6 parts, Rhizoma Chuanxiong 9 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 5 parts, the Radix Stemonae 10 parts, Rhizoma Sparganii 16 parts, Caulis Bambusae In Taenia 23 parts, Fructus Bruceae 10 parts, Cortex Moutan 15 parts, 6 parts, Radix Glycyrrhizae.
In the present invention's detailed description of the invention, described a kind ofly treat hyperosteogeny, the Chinese medicine composition of cervical spondylosis is made up of the crude drug of following weight portion: Radix Cyathulae 23 parts, Herba Verbenae 22 parts, Rhizoma Corydalis 21 parts, the Radix Astragali 11 parts, Herba Cistanches 15 parts, the Radix Paeoniae Alba 10 parts, Herba Ecliptae 14 parts, Fructus Ligustri Lucidi 11 parts, Semen Myristicae 5 parts, Radix Sanguisorbae 10 parts, Herba Lysimachiae 15 parts, Radix Polygalae 11 parts, Fructus Toosendan 8 parts, Rhizoma Chuanxiong 6 parts, Radix Et Rhizoma Rhei 9 parts, Herba Eupatorii 6 parts, Radix Platycodonis 8 parts, the Radix Stemonae 6 parts, Rhizoma Sparganii 21 parts, Caulis Bambusae In Taenia 17 parts, Fructus Bruceae 14 parts, Cortex Moutan 11 parts, 8 parts, Radix Glycyrrhizae.
The present invention provides on the other hand a kind of preparation method of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis, and it is characterized in that, the preparation method of this Chinese medicine composition comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Herba Verbenae, the Radix Astragali, Herba Cistanches, Herba Ecliptae, Radix Sanguisorbae, Herba Lysimachiae, Radix Polygalae, Radix Platycodonis, Caulis Bambusae In Taenia, Radix Glycyrrhizae are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C is the extractum (I) of 1.15-1.25;
(3) Radix Cyathulae, Rhizoma Corydalis, the Radix Paeoniae Alba, Fructus Ligustri Lucidi, Semen Myristicae, Fructus Toosendan, Radix Et Rhizoma Rhei, Herba Eupatorii, the Radix Stemonae, Rhizoma Sparganii, Fructus Bruceae, Cortex Moutan are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C is the extractum (II) of 1.15-1.25;
(4) by step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, to obtain final product.
In a concrete embodiment of the present invention, wherein add the soak by water 3 times accounting for gross weight 10 times amount in step (2), each 1.5 hours; Account in step (3) in the alcoholic solution of 85% of gross weight 10 times amount and extract 2 times, each 3 hours.
A kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis of the present invention, also can soak by water method or directly pulverize method preparation.The conventional method of Chinese medicine preparation can be adopted to be prepared into any traditional oral preparation.Described oral formulations is capsule, pill, powder, tablet, granule.
Chinese medicine composition of the present invention, based on the dialectical prescription of tcm theory, there is effect of blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, liver and kidney tonifying, bone and muscle strengthening, expelling wind and cold, heat-clearing and toxic substances removing, invigorating the spleen and replenishing QI, can be used for treating hyperosteogeny, cervical spondylosis, also can be used for the diseases such as treatment lumbago, skelalgia, numb limbs and tense tendons, intervertebral disk hernia, scapulohumeral periarthritis, lumbar muscle strain, have no side effect, therapeutic effect is remarkable.
Detailed description of the invention
Embodiment 1:
Treat a Chinese medicine composition for hyperosteogeny, cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae 20 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 20 parts, the Radix Astragali 13 parts, Herba Cistanches 12 parts, the Radix Paeoniae Alba 12 parts, Herba Ecliptae 13 parts, Fructus Ligustri Lucidi 12 parts, Semen Myristicae 8 parts, Radix Sanguisorbae 7 parts, Herba Lysimachiae 12 parts, Radix Polygalae 13 parts, Fructus Toosendan 7 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 7 parts, the Radix Stemonae 7 parts, Rhizoma Sparganii 20 parts, Caulis Bambusae In Taenia 20 parts, Fructus Bruceae 12 parts, Cortex Moutan 13 parts, 8 parts, Radix Glycyrrhizae;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 2:
Treat a Chinese medicine composition for hyperosteogeny, cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae 20 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 20 parts, the Radix Astragali 13 parts, Herba Cistanches 12 parts, the Radix Paeoniae Alba 12 parts, Herba Ecliptae 13 parts, Fructus Ligustri Lucidi 12 parts, Semen Myristicae 8 parts, Radix Sanguisorbae 7 parts, Herba Lysimachiae 12 parts, Radix Polygalae 13 parts, Fructus Toosendan 7 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 7 parts, the Radix Stemonae 7 parts, Rhizoma Sparganii 20 parts, Caulis Bambusae In Taenia 20 parts, Fructus Bruceae 12 parts, Cortex Moutan 13 parts, 8 parts, Radix Glycyrrhizae;
Preparation method comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Herba Verbenae, the Radix Astragali, Herba Cistanches, Herba Ecliptae, Radix Sanguisorbae, Herba Lysimachiae, Radix Polygalae, Radix Platycodonis, Caulis Bambusae In Taenia, Radix Glycyrrhizae are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C is the extractum (I) of 1.15-1.25;
(3) Radix Cyathulae, Rhizoma Corydalis, the Radix Paeoniae Alba, Fructus Ligustri Lucidi, Semen Myristicae, Fructus Toosendan, Radix Et Rhizoma Rhei, Herba Eupatorii, the Radix Stemonae, Rhizoma Sparganii, Fructus Bruceae, Cortex Moutan are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C is the extractum (II) of 1.15-1.25;
(4) by step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, incapsulate and get final product.
Embodiment 3:
Treat a Chinese medicine composition for hyperosteogeny, cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae 20 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 20 parts, the Radix Astragali 13 parts, Herba Cistanches 12 parts, the Radix Paeoniae Alba 12 parts, Herba Ecliptae 13 parts, Fructus Ligustri Lucidi 12 parts, Semen Myristicae 8 parts, Radix Sanguisorbae 7 parts, Herba Lysimachiae 12 parts, Radix Polygalae 13 parts, Fructus Toosendan 7 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 7 parts, the Radix Stemonae 7 parts, Rhizoma Sparganii 20 parts, Caulis Bambusae In Taenia 20 parts, Fructus Bruceae 12 parts, Cortex Moutan 13 parts, 8 parts, Radix Glycyrrhizae;
Each crude drug is dry at 45 DEG C, be cooled to room temperature, pulverize state, and mix homogeneously, load snap fit capsule, to obtain final product.
Embodiment 4:
Treat a Chinese medicine composition for hyperosteogeny, cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae 16 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 17 parts, the Radix Astragali 14 parts, Herba Cistanches 11 parts, the Radix Paeoniae Alba 13 parts, Herba Ecliptae 12 parts, Fructus Ligustri Lucidi 14 parts, Semen Myristicae 6 parts, Radix Sanguisorbae 9 parts, Herba Lysimachiae 11 parts, Radix Polygalae 14 parts, Fructus Toosendan 6 parts, Rhizoma Chuanxiong 9 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 5 parts, the Radix Stemonae 10 parts, Rhizoma Sparganii 16 parts, Caulis Bambusae In Taenia 23 parts, Fructus Bruceae 10 parts, Cortex Moutan 15 parts, 6 parts, Radix Glycyrrhizae
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 5:
Treat a Chinese medicine composition for hyperosteogeny, cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae 23 parts, Herba Verbenae 22 parts, Rhizoma Corydalis 21 parts, the Radix Astragali 11 parts, Herba Cistanches 15 parts, the Radix Paeoniae Alba 10 parts, Herba Ecliptae 14 parts, Fructus Ligustri Lucidi 11 parts, Semen Myristicae 5 parts, Radix Sanguisorbae 10 parts, Herba Lysimachiae 15 parts, Radix Polygalae 11 parts, Fructus Toosendan 8 parts, Rhizoma Chuanxiong 6 parts, Radix Et Rhizoma Rhei 9 parts, Herba Eupatorii 6 parts, Radix Platycodonis 8 parts, the Radix Stemonae 6 parts, Rhizoma Sparganii 21 parts, Caulis Bambusae In Taenia 17 parts, Fructus Bruceae 14 parts, Cortex Moutan 11 parts, 8 parts, Radix Glycyrrhizae;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 6 Chinese medicine composition of the present invention is on the impact of mice acetic acid twisting
Choose Kunming mouse 50, male and female half and half, body weight 23-25g, be divided into 5 groups at random, dosage group and high dose group of the present invention in matched group, tramadol group, low dose group of the present invention, the present invention, often organize 10.Matched group gavage isometric(al) distilled water, tramadol group gavage tramadol medicinal liquid, in low dose group of the present invention, the present invention, dosage group and high dose group of the present invention are according to the medicinal liquid of the dosage gavage embodiment of the present invention 1 preparation listed in table 1, are all administered once.After each group of administration 60min, only inject 0.7% acetum 0.2ml/.With abdominal part indent, buttocks is raised, and stretching hind leg is writhing index, observes writhing response number of times and first time writhing time of occurrence (incubation period) in injection 15min, the results are shown in Table 1.
Result in table 1 shows, Chinese medicine composition of the present invention can reduce the writhing number of times (P < 0.01) of acetic acid induced mice stomachache reaction, and the incubation period (P < 0.01) of panic attacks can be extended, illustrate that Chinese medicine composition of the present invention has good analgesic activity.
Table 1 Chinese medicine composition of the present invention is on the impact of mice acetic acid twisting
| Group | Dosage (g/kg) | Number of elements | Incubation period (second) | Writhing number of times (secondary/15min) |
| Matched group | ---- | 10 | 203±135 | 26±14 |
| Tramadol group | 0.01 | 10 | 904±13 *** | 0±0 *** |
| Low dose group of the present invention | 2.5 | 10 | 519±265 | 16±12 |
| Dosage group in the present invention | 5 | 10 | 558±132 ** | 13±5 |
| High dose group of the present invention | 10 | 10 | 623±323 ** | 5±8 ** |
Note:
*p < 0.05
*p < 0.01
* *p < 0.001
Embodiment 6 clinical data
1, physical data
Choose 100 routine hyperosteogeny patients, man 50 example, female 50 example; The oldest person 74 years old, minimum 29 years old, all patients all took the photograph sheet through x-ray and make a definite diagnosis.
2, Therapeutic Method
Use capsule obtained in embodiment 2 to treat, every day twice, each 2, treating 4 weeks is a course for the treatment of.
3, efficacy assessment standard
Cure: sings and symptoms disappear, vertebra and joint motion normal.
Effective: sings and symptoms disappears, vertebra and joint motion normal, have slight neck, shoulder or waist lower limb uncomfortable time tired.
Invalid: pain does not alleviate, symptom is not improved.
4, result
After 3 courses for the treatment of, cure 53 examples, effective 45 examples, invalid 2 examples, the total effective rate of traditional Chinese medicine composition for treating hyperosteogeny of the present invention reaches 98%.
Claims (8)
1. treat a Chinese medicine composition for hyperosteogeny, cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae, Herba Verbenae, Rhizoma Corydalis, the Radix Astragali.
2. a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis according to claim 1, is made up of the crude drug of following weight portion: Radix Cyathulae 15-25 part, Herba Verbenae 15-25 part, Rhizoma Corydalis 15-25 part, Radix Astragali 10-15 part.
3. one according to claim 1 treats hyperosteogeny, the Chinese medicine composition of cervical spondylosis, be made up of the crude drug of following weight portion: Radix Cyathulae 15-25 part, Herba Verbenae 15-25 part, Rhizoma Corydalis 15-25 part, Radix Astragali 10-15 part, Herba Cistanches 10-15 part, Radix Paeoniae Alba 10-15 part, Herba Ecliptae 10-15 part, Fructus Ligustri Lucidi 10-15 part, Semen Myristicae 5-10 part, Radix Sanguisorbae 5-10 part, Herba Lysimachiae 10-15 part, Radix Polygalae 10-15 part, Fructus Toosendan 5-10 part, Rhizoma Chuanxiong 5-10 part, Radix Et Rhizoma Rhei 5-10 part, Herba Eupatorii 5-10 part, Radix Platycodonis 5-10 part, Radix Stemonae 5-10 part, Rhizoma Sparganii 15-25 part, Caulis Bambusae In Taenia 15-25 part, Fructus Bruceae 10-15 part, Cortex Moutan 10-15 part, Radix Glycyrrhizae 5-10 part.
4. a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis according to claim 1, is made up of the crude drug of following weight portion: Radix Cyathulae 20 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 20 parts, the Radix Astragali 13 parts, Herba Cistanches 12 parts, the Radix Paeoniae Alba 12 parts, Herba Ecliptae 13 parts, Fructus Ligustri Lucidi 12 parts, Semen Myristicae 8 parts, Radix Sanguisorbae 7 parts, Herba Lysimachiae 12 parts, Radix Polygalae 13 parts, Fructus Toosendan 7 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 7 parts, the Radix Stemonae 7 parts, Rhizoma Sparganii 20 parts, Caulis Bambusae In Taenia 20 parts, Fructus Bruceae 12 parts, Cortex Moutan 13 parts, 8 parts, Radix Glycyrrhizae.
5. a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis according to claim 1, is made up of the crude drug of following weight portion: Radix Cyathulae 16 parts, Herba Verbenae 20 parts, Rhizoma Corydalis 17 parts, the Radix Astragali 14 parts, Herba Cistanches 11 parts, the Radix Paeoniae Alba 13 parts, Herba Ecliptae 12 parts, Fructus Ligustri Lucidi 14 parts, Semen Myristicae 6 parts, Radix Sanguisorbae 9 parts, Herba Lysimachiae 11 parts, Radix Polygalae 14 parts, Fructus Toosendan 6 parts, Rhizoma Chuanxiong 9 parts, Radix Et Rhizoma Rhei 7 parts, Herba Eupatorii 8 parts, Radix Platycodonis 5 parts, the Radix Stemonae 10 parts, Rhizoma Sparganii 16 parts, Caulis Bambusae In Taenia 23 parts, Fructus Bruceae 10 parts, Cortex Moutan 15 parts, 6 parts, Radix Glycyrrhizae.
6. a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis according to claim 1, is made up of the crude drug of following weight portion: Radix Cyathulae 23 parts, Herba Verbenae 22 parts, Rhizoma Corydalis 21 parts, the Radix Astragali 11 parts, Herba Cistanches 15 parts, the Radix Paeoniae Alba 10 parts, Herba Ecliptae 14 parts, Fructus Ligustri Lucidi 11 parts, Semen Myristicae 5 parts, Radix Sanguisorbae 10 parts, Herba Lysimachiae 15 parts, Radix Polygalae 11 parts, Fructus Toosendan 8 parts, Rhizoma Chuanxiong 6 parts, Radix Et Rhizoma Rhei 9 parts, Herba Eupatorii 6 parts, Radix Platycodonis 8 parts, the Radix Stemonae 6 parts, Rhizoma Sparganii 21 parts, Caulis Bambusae In Taenia 17 parts, Fructus Bruceae 14 parts, Cortex Moutan 11 parts, 8 parts, Radix Glycyrrhizae.
7. a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis according to any one of claim 1-6, is characterized in that, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.
8. a kind of Chinese medicine composition for the treatment of hyperosteogeny, cervical spondylosis according to claim 7, is characterized in that, described oral formulations is capsule, pill, powder, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610017575.3A CN105412378A (en) | 2016-01-12 | 2016-01-12 | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610017575.3A CN105412378A (en) | 2016-01-12 | 2016-01-12 | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105412378A true CN105412378A (en) | 2016-03-23 |
Family
ID=55491225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610017575.3A Pending CN105412378A (en) | 2016-01-12 | 2016-01-12 | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105412378A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920391A (en) * | 2016-05-09 | 2016-09-07 | 鞠志峰 | Medicine for treating hyperostosis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1438028A (en) * | 2003-03-24 | 2003-08-27 | 陈玉祥 | Plaster for treating lumbar vertebra osteoproliferation |
| CN101703645A (en) * | 2009-11-26 | 2010-05-12 | 黄远吉 | Chinese medicinal composition for treating cervical vertebra hyperosteogeny |
| CN102100754A (en) * | 2009-12-17 | 2011-06-22 | 天津市中宝制药有限公司 | Chinese medicinal composition for treating osteoproliferation |
| CN102961483A (en) * | 2012-12-07 | 2013-03-13 | 郭玉玲 | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof |
-
2016
- 2016-01-12 CN CN201610017575.3A patent/CN105412378A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1438028A (en) * | 2003-03-24 | 2003-08-27 | 陈玉祥 | Plaster for treating lumbar vertebra osteoproliferation |
| CN101703645A (en) * | 2009-11-26 | 2010-05-12 | 黄远吉 | Chinese medicinal composition for treating cervical vertebra hyperosteogeny |
| CN102100754A (en) * | 2009-12-17 | 2011-06-22 | 天津市中宝制药有限公司 | Chinese medicinal composition for treating osteoproliferation |
| CN102961483A (en) * | 2012-12-07 | 2013-03-13 | 郭玉玲 | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920391A (en) * | 2016-05-09 | 2016-09-07 | 鞠志峰 | Medicine for treating hyperostosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100402066C (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN101972443B (en) | Chinese medicinal formula for treating chronic gastritis | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN103495055A (en) | Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof | |
| CN104840599A (en) | Medicine for treating ankylosing spondylitis | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN104998202A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN105012612A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN105412378A (en) | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104491832A (en) | Traditional Chinese medicine composition used for treating osteoproliferation | |
| CN111494501B (en) | Kidney-strengthening and collateral-dredging composition, medicine and preparation method thereof | |
| CN104027411A (en) | Traditional Chinese medicine for treating osteoporosis | |
| CN102293836A (en) | Chinese patent drug for treating swollen pains and numb of waist and legs and functional disorder and preparation method | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN104840814A (en) | Traditional Chinese medicine combination for treating senile femoral head necrosis | |
| CN105232609A (en) | Traditional Chinese medicine combination treating functional dyspepsia | |
| CN105727000B (en) | Chinese medicine composition and the application in vertebral artery type of cervical spondylosis treatment | |
| CN104147263A (en) | Traditional Chinese medicine for treating neurodermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination |